Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy

被引:104
作者
Anderson, Peter M. [1 ,2 ]
Lalla, Rajesh V. [3 ]
机构
[1] Cleveland Clin, Pediat Inst, Pediat Hematol Oncol & Bone Marrow Transplant, Cleveland, OH 44195 USA
[2] Taussig Canc Inst, Cleveland, OH 44195 USA
[3] UConn Hlth, Sch Dent Med, Farmington, CT 06030 USA
关键词
glutamine; trehalose; mucositis; radiation injury; chemotherapy associated malnutrition; glutathione; amino acid supplementation in cancer; INDUCED ORAL MUCOSITIS; CLINICAL-PRACTICE GUIDELINES; BONE-MARROW-TRANSPLANTATION; ALIMENTARY-TRACT MUCOSITIS; EARLY LYMPHOCYTE RECOVERY; DOUBLE-BLIND; NECK-CANCER; BREAST-CANCER; DIETARY GLUTAMINE; PREVENTION;
D O I
10.3390/nu12061675
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glutamine is a major dietary amino acid that is both a fuel and nitrogen donor for healing tissues damaged by chemotherapy and radiation. Evidence supports the benefit of oral (enteral) glutamine to reduce symptoms and improve and/or maintain quality of life of cancer patients. Benefits include not only better nutrition, but also decreased mucosal damage (mucositis, stomatitis, pharyngitis, esophagitis, and enteritis). Glutamine supplementation in a high protein diet (10 grams/day) + disaccharides, such as sucrose and/or trehalose, is a combination that increases glutamine uptake by mucosal cells. This increased topical effect can reduce painful mucosal symptoms and ulceration associated with chemotherapy and radiation in the head and neck region, esophagus, stomach and small intestine. Topical and oral glutamine seem to be the preferred routes for this amino acid to promote mucosal healing during and after cancer treatment.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 111 条
  • [1] Emerging evidence on the pathobiology of mucositis
    Al-Dasooqi, Noor
    Sonis, Stephen T.
    Bowen, Joanne M.
    Bateman, Emma
    Blijlevens, Nicole
    Gibson, Rachel J.
    Logan, Richard M.
    Nair, Raj G.
    Stringer, Andrea M.
    Yazbeck, Roger
    Elad, Sharon
    Lalla, Rajesh V.
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (11) : 3233 - 3241
  • [2] Monitoring of methotrexate and 7-hydroxymethotrexate in saliva from children with acute lymphoblastic leukemia receiving high-dose consolidation treatment: Relation to oral mucositis
    Albertioni, F
    Rask, C
    Schroeder, H
    Peterson, C
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 119 - 124
  • [3] Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review
    Aleixo, G. F. P.
    Williams, G. R.
    Nyrop, K. A.
    Muss, H. B.
    Shachar, S. S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (03) : 569 - 579
  • [4] From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
    Altman, Brian J.
    Stine, Zachary E.
    Dang, Chi V.
    [J]. NATURE REVIEWS CANCER, 2016, 16 (11) : 749 - 749
  • [5] Anderson P.M, 2014, P 46 C INT SOC PAED
  • [6] Predicting and Facilitating Survival of Pediatric Cancer Patients: The ALC Story
    Anderson, Pete
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 55 (06) : 1041 - 1042
  • [7] The Therapeutic Alliance: Adapting to the Unthinkable With Better Information
    Anderson, Pete
    Kaye, Laura
    [J]. HEALTH COMMUNICATION, 2009, 24 (08) : 775 - 778
  • [8] Immune Therapy for Sarcomas
    Anderson, Peter M.
    [J]. IMMUNOTHERAPY, 2017, 995 : 127 - 140
  • [9] Anderson PM, 1998, CANCER, V83, P1433, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1433::AID-CNCR22>3.0.CO
  • [10] 2-4